Literature DB >> 23167426

Clinical predictive value of serum angiogenic factor in patients with osteosarcoma.

Zhe Chen1, Qi-Xin Chen, Zhao-Yang Hou, Jiong Hu, Yan-Guang Cao.   

Abstract

OBJECTIVE: To explore serum angiogenic factor expression in patients with osteosarcoma and its relationship with metastasis.
METHODS: Immunohistochemistry was used to test the expression of CD34 and FVIII-Rag in osteosarcoma tissues of 36 patients (osteosarcoma group) and microvessel density (MVD) was also recorded. In addition, ELISA was used to test the level of vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), transforming growth factor-β1 (TGF-β1) and endostatin (ES) in the osteosarcoma group and in a control group.
RESULTS: VEGF and ES level were significantly higher than in the control group before operation (P<0.01), VEGF, bFGF and TGF-β1 correlating with the ES level (P<.01). Serum VEGF and ES levels of osteosarcoma patients before surgery were closely related to relapse and metastasis; moreover, serum VEGF increased with MVD (P<0.01). Postoperative VEGF and ES levels were lower than the preoperation values (P<0.01); ES level in relapse group was significantly higher than that of the non-relapse group (P<0.01).
CONCLUSION: Preoperative serum VEGF and postoperative ES levels have great predictive value with regard to relapse of osteosarcoma patients.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23167426     DOI: 10.7314/apjcp.2012.13.9.4823

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  4 in total

Review 1.  A systematic review of vascular endothelial growth factor expression as a biomarker of prognosis in patients with osteosarcoma.

Authors:  Ding Chen; Ye-Jia Zhang; Ke-wei Zhu; Wan-Chun Wang
Journal:  Tumour Biol       Date:  2013-04-16

2.  High-level expression of periostin is significantly correlated with tumour angiogenesis and poor prognosis in osteosarcoma.

Authors:  Fei Hu; Xi-Fu Shang; Wei Wang; Wei Jiang; Ce Fang; Dong Tan; Hang-Cheng Zhou
Journal:  Int J Exp Pathol       Date:  2016-03-30       Impact factor: 1.925

3.  Prognostic impact of blood and urinary angiogenic factor levels at diagnosis and during treatment in patients with osteosarcoma: a prospective study.

Authors:  Marie-Dominique Tabone; Laurence Brugières; Sophie Piperno-Neumann; Marie-Ange Selva; Perrine Marec-Bérard; Hélène Pacquement; Cyril Lervat; Nadège Corradini; Jean-Claude Gentet; Rémy Couderc; Aurélie Chevance; Céline Mahier-Ait Oukhatar; Natacha Entz-Werle; Jean-Yves Blay; Marie-Cecile Le Deley
Journal:  BMC Cancer       Date:  2017-06-15       Impact factor: 4.430

4.  Apurinic/apyrimidinic endonuclease 1 regulates angiogenesis in a transforming growth factor β-dependent manner in human osteosarcoma.

Authors:  Xuan Jiang; Jinlu Shan; Nan Dai; Zhaoyang Zhong; Yi Qing; Yuxing Yang; Shiheng Zhang; Chongyi Li; Jiangdong Sui; Tao Ren; Mengxia Li; Dong Wang
Journal:  Cancer Sci       Date:  2015-09-25       Impact factor: 6.716

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.